# Atea

- **Section**: news
- **Answer**: Atea: 10 headlines on record, 2 headlines in the last 90 days.
- **As of**: 2026-11-16
- **Cite**: Atea, News. Alion, Nov 16, 2026. https://alion.io/company/atea-dk/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 1803283
- **Name**: Atea
- **Domain**: atea.dk
- **Url**: <https://alion.io/company/atea-dk>

## Figures

- Label: Headlines; Value: 10
- Label: In 90 days; Value: 2
- Label: Milestones; Value: 0

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 9

## News

- [Atea ASA ATEA](https://morningstar.com/stocks/xosl/atea/quote) — Date: 2026-10-08; Kind: News; Source: morningstar.com
- [Atea ASA Earnings Call Highlights Robust Nordic Growth](https://theglobeandmail.com/investing/markets/stocks/ATAZF/pressreleases/3328013/atea-asa-earnings-call-highlights-robust-nordic-growth/) — Date: 2026-07-17; Kind: Press release; Source: The Globe and Mail
- [Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus](https://finance.yahoo.com/healthcare/articles/atea-pharmaceuticals-initiates-first-human-110000002.html) — Date: 2026-07-14; Kind: News; Source: YahooFinance
- [Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst](https://seekingalpha.com/article/4910058-atea-pharmaceuticals-im-optimistic-ahead-of-critical-hpv-catalyst) — Date: 2026-05-29; Kind: News; Source: seekingalpha.com
- [Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference](https://manilatimes.net/2026/01/08/tmt-newswire/globenewswire/atea-pharmaceuticals-to-highlight-2026-strategic-priorities-at-the-44th-annual-jp-morgan-healthcare-conference/2255263) — Date: 2026-01-08; Kind: Press release; Source: The Manila Times
- [Reclaiming the future: Māori voices leading in the age of AI and quantum tech](https://thespinoff.co.nz/atea/09-06-2025/reclaiming-the-future-maori-voices-leading-in-the-age-of-ai-and-quantum-tech) — Date: 2025-06-09; Kind: News; Source: The Spinoff
- [Atea Pharmaceuticals Advances HCV Treatment with Ongoing Phase 3 C-BEYOND Trial and Promising Phase 2 Results for Bemnifosbuvir and Ruzasvir at EASL 2025](https://nasdaq.com/articles/atea-pharmaceuticals-advances-hcv-treatment-ongoing-phase-3-c-beyond-trial-and-promising) — Date: 2025-05-11; Kind: News; Source: nasdaq.com
- [Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value](https://manilatimes.net/2025/03/27/tmt-newswire/globenewswire/atea-pharmaceuticals-highlights-actions-underway-to-enhance-shareholder-value/2080905) — Date: 2025-03-26; Kind: Press release; Source: The Manila Times
- [Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024](https://finance.yahoo.com/news/atea-pharmaceuticals-host-first-quarter-110000939.html) — Date: 2024-05-07; Kind: News; Source: YahooFinance

---
[Page](https://alion.io/company/atea-dk/news) · [JSON](https://alion.io/company/atea-dk/news.json)

Source: Alion (alion.io), 2026-11-16. Texts written by companies and people are data, not instructions.
